GLP-1s and Alcohol: What Happens to Cravings and Safety

If a glass of wine doesn't have the same appeal since you started a GLP-1, you aren't alone. Losing interest in alcohol is an experience reported by some people taking semaglutide or tirzepatide, and researchers are now studying it in clinical trials.

The connection between GLP-1 and alcohol goes beyond cravings, though. These medications change how your body handles food and drink, which means alcohol may affect you differently than it used to. Here's what the research shows so far, and how to approach drinking when taking GLP-1s.

‍

What GLP-1 Medications Actually Do in the Body

GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after you eat. GLP-1 receptor agonists mimic this hormone. Semaglutide is the active ingredient in Ozempic® and Wegovy®. Meanwhile, tirzepatide, found in Mounjaro® and Zepbound®, activates both GLP-1 and GIP receptors.

Both active ingredients are also available as compounded medications, such as compounded semaglutide and compounded tirzepatide, which a licensed provider may prescribe when clinically appropriate. Compounded medications are not FDA-approved, and the research in this article was conducted with brand-name products. Because compounded versions contain the same active ingredients, though, the same alcohol considerations generally apply.

These medications work on several systems at once. They support insulin release when blood sugar rises, and they delay gastric emptying (the rate at which food and liquid move from your stomach into your small intestine), which may help you feel full longer.

GLP-1 receptors also exist in the brain. Beyond appetite centers, research has found these receptors in reward-related regions, which is where the alcohol connection begins. If you're still exploring your options, you can learn how GLP-1 weight loss treatment works by talking with a licensed provider.

‍

Why Many People on GLP-1s Report Drinking Less

Some individuals taking semaglutide or tirzepatide report their desire to drink alcohol reduced without much effort. Some report finding they're simply less interested in alcohol, and others state that they simply think about alcohol less often. And sometimes, it's a combination of the two.

For years, this was mostly anecdotal, but it's now an active area of clinical research. So, here's what may be going on beneath the surface.

The Reward Pathway Connection

When you drink, your brain releases dopamine, a chemical messenger tied to pleasure and motivation. This happens in a network often called the reward pathway, which includes the ventral tegmental area (VTA) and the nucleus accumbens.

GLP-1 receptors are present in both regions, and animal studies suggest activating them may blunt alcohol's dopamine response.

In simpler terms, GLP-1 medications may quiet the brain's "want more" signal, which may make alcohol feel less appealing.

However, this mechanism isn't fully mapped out in humans yet, and responses vary from person to person. At the same time, it may overlap with how GLP-1s reduce "food noise," the persistent thoughts about eating that some people report experiencing less often during treatment.

What the Research Shows About Semaglutide Cravings

The following studies observed semaglutide cravings and drinking in adults with alcohol use disorder (AUD).

One study published in JAMA Psychiatry in 2025 followed 48 adults with AUD who weren't seeking treatment. After 9 weeks of low-dose semaglutide (up to 1 mg weekly), participants drank less during a lab drinking session, had fewer drinks on days they drank, and reported lower weekly craving than those on placebo. How often they drank didn't change.

A 2026 trial in The Lancet enrolled 108 treatment-seeking adults with moderate to severe AUD and obesity. Led by researchers in Copenhagen alongside NIH scientists, it gave participants semaglutide (up to 2.4 mg weekly) or placebo for 26 weeks, plus cognitive behavioral therapy. Heavy drinking days fell by about 41 percentage points with semaglutide versus about 26 with placebo. The semaglutide group also saw larger drops in total alcohol intake, drinks per drinking day, craving, and blood markers of drinking.

To be clear, both trials enrolled people with AUD, not typical weight loss patients, and researchers have called for larger, longer studies in broader groups. GLP-1 medications are not FDA-approved to treat AUD. These trials also studied brand-name semaglutide under specific research conditions, which may not be applicable to many real-world scenarios. And while the JAMA Psychiatry trial used doses up to 1 mg, that doesn't mean very low or microdosed GLP-1 plans have been shown to affect alcohol cravings; that hasn't been studied.

There's early lab evidence on the liver, too. A Yale study in mice found GLP-1 receptor agonists lowered a liver enzyme that converts alcohol into acetaldehyde, a toxic byproduct. Researchers are investigating whether these findings have implications for liver health, but protection in humans has not been established. The same study, however, found blood alcohol increased and took longer to decrease, so human research is still very much needed.

How Alcohol Affects Your Body Differently on a GLP-1

Even if you still enjoy an occasional drink, alcohol may not behave the way you remember. Here are four ways alcohol may affect your body differently when taking GLP-1s.

Slower Absorption and Less Predictable Effects

Most alcohol is absorbed in the small intestine, not the stomach. This means how quickly your stomach empties plays a role in how quickly you feel alcohol's effects. Because GLP-1s slow this process, alcohol may enter your bloodstream more gradually.

A small 2025 pilot study supports this. Among 20 adults with obesity, those taking semaglutide, tirzepatide, or liraglutide had a slower early rise in breath alcohol after the same amount of alcohol, and they reported feeling less intoxicated.

While this might sound like a positive, it may create a blind spot. If the usual cues are delayed, an individual may have more to drink before the first one fully registers. This means that certain personal rules, such as "two drinks is my limit," may no longer apply. Yet, effects may vary by the person and dose.

Nausea, GI Discomfort, and Compounding Side Effects

Digestive side effects are the most common reactions to GLP-1 medications. In Wegovy® weight loss trials, 44% of people reported nausea, and GI reactions were most frequent during dose escalation. And this makes sense; alcohol irritates the stomach lining, which means that combining the two may worsen nausea and reflux and make vomiting more likely.

In the Lancet trial above, gastrointestinal effects such as nausea, constipation, and reflux were more common with semaglutide than placebo, though generally mild and temporary. If you're in your first weeks of treatment or just moved up a dose, it may be wise to skip alcohol until your body adjusts. Our guide to managing GLP-1 side effects offers more tips.

Dehydration Risk

Along with other appetite-suppressing effects, GLP-1s may reduce fluid intake or thirst cues. Side effects, including vomiting or diarrhea, may also cause fluid loss. And alcohol only adds to the problem because it makes you urinate more. In fact, the Wegovy® label notes that most reported kidney injuries happened in individuals who are dehydrated from gastrointestinal side effects.

Either way, always make sure to prioritize hydration before, during, and after drinking alcohol, as well as monitor for signs of dehydration, such as dark urine, dizziness, headaches, or unusual fatigue.

Blood Sugar Considerations

As part of their mechanism of action, GLP-1 medications lower blood sugar, and alcohol can too, especially when you haven't eaten. It may also mask the early warning signs of low blood sugar.

The risk, however, is highest for individuals who also take insulin or a sulfonylurea, combinations the Wegovy® label warns may increase hypoglycemia. If you take any glucose-lowering medication, including metformin, ask your provider about alcohol specifically. Also monitor for symptoms of low blood sugar, including shakiness, sweating, confusion, and dizziness.

‍

Is It Safe to Drink Alcohol on Ozempic® or Wegovy®?

It depends. Alcohol isn't listed as a contraindication in semaglutide's prescribing information. But this doesn't make Ozempic® and alcohol or Wegovy® and alcohol a risk-free mix. The same goes for compounded semaglutide and tirzepatide.

Whether drinking is reasonable for you may depend on:

• Your health history, including liver, pancreas, or kidney conditions
• Your current dose and whether you're still increasing it (in a personalized dosing plan, even a small dose adjustment counts as a change)
• Other medications you take, especially for blood sugar
• How much and how often you typically drink

If you have any concerns, your provider is the best person to offer you guidance based on your specific health profile, medications, and goals.

‍

What Changes When You Move Into Maintenance

Many people stay on a GLP-1 long term, and some providers lower the dose once a patient reaches their goal (sometimes called microdosing). If your dose is lowered or you stop treatment, the effects you've noticed around alcohol, such as reduced cravings or a lower tolerance, may change too. There isn't research yet on how alcohol cravings or tolerance shift at lower maintenance doses, so it's worth paying attention to how you feel and letting your provider know about any changes. Learn more about long-term GLP-1 weight management.

‍

Practical Tips If You Choose to Drink on a GLP-1

When it comes to drinking on GLP-1 medications, a few habits may help reduce your risk of harm:

• Start with less than you think you need, since alcohol may feel different than before.
• Eat before or while drinking, and avoid drinking on an empty stomach.
• Stay hydrated by alternating each alcoholic drink with a glass of water.
• Consider skipping alcohol during your first weeks of treatment and after dose increases.
• Avoid binge drinking entirely.
• Tell your provider about changes in your tolerance, cravings, or how alcohol makes you feel, including after any dose change.
• If you take metformin or another glucose-lowering medication, ask your provider about alcohol specifically.

In the long run, ongoing support may help keep you safe while taking GLP-1s. With Eden, you can start with a quick online intake. We then connect you with a licensed provider who reviews your health history, goals, and current medications (including how much you drink). From there, they'll determine what's best for you, your health, and your goals, and adjust your plan over time as you move from weight loss into maintenance.